Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-01 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 2616 | $61.25 - $63.87 | $161,416 |
| 2024-04-23 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 15000 | $61.92 - $61.92 | $928,845 |
| 2024-04-23 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 15000 | $1.79 - $1.79 | $26,850 |
| 2024-04-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
S | Common Stock | D | 8000 | $61.24 - $61.90 | $490,199 |
| 2024-04-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
M | Common Stock | A | 8000 | $5.35 - $5.35 | $42,800 |
| 2024-03-25 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 15000 | $66.87 - $67.50 | $1,003,978 |
| 2024-03-25 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 15000 | $1.79 - $1.79 | $26,850 |
| 2024-03-15 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
F | Common Stock | D | 1484 | $69.70 - $69.70 | $103,434 |
| 2024-03-15 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
A | Common Stock | A | 4099 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
S | Common Stock | D | 3000 | $73.08 - $74.69 | $221,133 |
| 2024-03-02 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
F | Common Stock | D | 2178 | $71.55 - $71.55 | $155,835 |
| 2024-02-29 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
A | Common Stock | A | 20000 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Vaxcyte, Inc. | Cowan Elvia
(SVP, FINANCE) |
S | Common Stock | D | 11678 | $73.08 - $74.90 | $865,069 |
| 2024-03-01 | Vaxcyte, Inc. | Cowan Elvia
(SVP, FINANCE) |
M | Common Stock | A | 11000 | $25.92 - $25.92 | $285,120 |
| 2024-03-02 | Vaxcyte, Inc. | Cowan Elvia
(SVP, FINANCE) |
F | Common Stock | D | 324 | $71.55 - $71.55 | $23,182 |
| 2024-02-29 | Vaxcyte, Inc. | Cowan Elvia
(SVP, FINANCE) |
A | Common Stock | A | 5400 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
S | Common Stock | D | 1667 | $73.03 - $74.77 | $122,905 |
| 2024-03-01 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
M | Common Stock | A | 1667 | $21.41 - $21.41 | $35,690 |
| 2024-03-02 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
F | Common Stock | D | 613 | $71.55 - $71.55 | $43,860 |
| 2024-02-29 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
A | Common Stock | A | 10500 | $0.00 - $0.00 | $0 |
| 2024-03-02 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
F | Common Stock | D | 3795 | $71.55 - $71.55 | $271,532 |
| 2024-02-29 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
A | Common Stock | A | 20000 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 2616 | $72.97 - $74.78 | $192,797 |
| 2024-03-02 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
F | Common Stock | D | 7967 | $71.55 - $71.55 | $570,038 |
| 2024-02-29 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
A | Common Stock | A | 45000 | $0.00 - $0.00 | $0 |
| 2024-02-01 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
S | Common Stock | D | 1667 | $72.22 - $75.39 | $123,142 |
| 2024-02-01 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
M | Common Stock | A | 1667 | $21.41 - $21.41 | $35,690 |
| 2024-02-01 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
S | Common Stock | D | 3000 | $72.18 - $75.28 | $221,625 |
| 2024-02-01 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
M | Common Stock | A | 3000 | $2.42 - $2.42 | $7,260 |
| 2024-02-01 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 2616 | $71.93 - $75.49 | $193,349 |
| 2024-01-23 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 15000 | $63.22 - $64.78 | $958,781 |
| 2024-01-23 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 15000 | $0.04 - $1.79 | $21,600 |
| 2024-01-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
S | Common Stock | D | 8000 | $60.27 - $63.35 | $485,877 |
| 2024-01-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
M | Common Stock | A | 8000 | $5.35 - $5.35 | $42,800 |
| 2024-01-02 | Vaxcyte, Inc. | Wassil Jim
(Chief Operating Officer) |
S | Common Stock | D | 3000 | $62.71 - $65.15 | $191,739 |
| 2024-01-02 | Vaxcyte, Inc. | Wassil Jim
(Chief Operating Officer) |
M | Common Stock | A | 3000 | $2.42 - $2.42 | $7,260 |
| 2023-12-26 | Vaxcyte, Inc. | PICKERING GRANT
(Chief Executive Officer) |
S | Common Stock | D | 15000 | $61.32 - $62.08 | $925,537 |
| 2023-12-22 | Vaxcyte, Inc. | PICKERING GRANT
(Chief Executive Officer) |
M | Common Stock | A | 19900 | $0.04 - $2.03 | $20,496 |
| 2023-12-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(President and CFO) |
S | Common Stock | D | 8000 | $60.17 - $60.79 | $481,416 |
| 2023-12-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(President and CFO) |
M | Common Stock | A | 8000 | $5.35 - $5.35 | $42,800 |
| 2023-12-01 | Vaxcyte, Inc. | Wassil Jim
(Chief Operating Officer) |
S | Common Stock | D | 3000 | $51.46 - $52.51 | $156,406 |
| 2023-12-01 | Vaxcyte, Inc. | Wassil Jim
(Chief Operating Officer) |
M | Common Stock | A | 3000 | $2.42 - $2.42 | $7,260 |
| 2023-11-20 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(President and CFO) |
S | Common Stock | D | 8000 | $51.12 - $51.95 | $409,062 |
| 2023-11-20 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(President and CFO) |
M | Common Stock | A | 8000 | $5.35 - $5.35 | $42,800 |
| 2023-11-09 | Vaxcyte, Inc. | Paya Carlos V
(Director) |
G | Common Stock | D | 3125 | $0.00 - $0.00 | $0 |
| 2023-11-09 | Vaxcyte, Inc. | Paya Carlos V
(Director) |
A | Common Stock | A | 3125 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |